CTRSP Research News

MMI Clinical & Translational Research Scholars Programme (CTRSP) alumni report on their industry placement & mentoring experiences during the programme and how it impacted on their post-PhD careers.

Please find the video interviews here


The MMI Clinical & Translational Research Scholars Programme is funded under the Programme for Research in Third Level Institutions (PRTLI) Cycle 5, and co-funded under the European Regional Development Fund (ERDF).

PRTLI5a

January 26, 2016
mmi-CTRSP-Alumni-updates-2016-2

CTRSP Alumni updates

MMI Clinical & Translational Research Scholars Programme (CTRSP) alumni report on their industry placement & mentoring experiences during the programme and how it impacted on their post-PhD careers. […]
July 31, 2014
IMG_0095(2)

CTRSP scholar Oisin Gough becomes ICON-GPA Life Sciences Ambassador

 Oisin Gough received a Gaelic Players Association (GPA) postgraduate scholarship in 2014 and has now been invited to become an ICON-GPA Life Sciences Ambassador under a […]
October 31, 2013
Picture3

MMI CTRSP Scholars Write About Their Research

The MMI Clinical & Translational Research Scholars Programme began in 2011 funded through PRTLI Cycle 5. The CTRSP is a unique cross-institutional programme that develops graduates […]
August 3, 2012
Partners3(1)

High level of industry engagement in MMI CTRSP

Molecular Medicine Ireland is delighted with the response to our request for industry and commercially relevant work placements for students on the MMI Clinical & Translational Research Scholars Programme. Over 20 organisations are offering a variety of 10-15 week placement experiences in the clinical and translational research environment. These include biomarker assay development; medical device and diagnostic product R&D; preparing pre-clinical and clinical protocols; identification and validation of therapeutic targets; developing disease models; clinical validation activities; characterisation of therapeutic bacterial strains; design analysis and reporting of observational research studies and clinical trials; pharmacovigilance quality and regulatory affairs; high content screening technology development; pharmaceutical marketing; Clinical Research Organisation R&D;.